Leaders in COPD care and research
The CanCOLD study, hosted at the RI-MUHC, is one of the most valuable resources in the world to support research on the causes and burden of chronic obstructive pulmonary disease.
Validating hospital data for research and surveillance
Statistical analysis by an RI-MUHC team confirms the validity of hospital diagnostic codes in identifying SARS-CoV-2 infection
Triple-negative breast cancer: a new clinical study opens new and promising therapeutic prospects
The RI-MUHC will host a new Phase 3 randomized clinical trial called TROPION-Breast04, as announced today...
Where the biology of aging meets the study of health and chronic disease
The Bone, Muscle and Geroscience Research Group at the RI-MUHC is leading the way in Canadian...